Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 2Triple Negative Breast Neoplasms 1Neoplasm Metastasis 1Leiomyoma 1Cardiovascular Diseases 1Anatomic Stage I Breast Cancer AJCC v8 1Advanced Biliary Tract Carcinoma 1

Interventions

Specimen Handling 4Docetaxel 3pertuzumab 2pembrolizumab 2Trastuzumab 2Taxes 2Paclitaxel 2High-Energy Shock Waves 2Cyclophosphamide 2Carboplatin 2Biopsy 2trastuzumab biosimilar HLX02 1fisetin 1Watchful Waiting 1Surgical Procedures, Operative 1Simvastatin 1PF-05280014 1Ontruzant 1Ogivri 1Observation 1Minoxidil 1Methods 1Metformin 1Magnetic Resonance Spectroscopy 1Letrozole 1Immunoglobulin G 1Educational Status 1Early Intervention, Educational 1Doxorubicin 1Disulfides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Anatomic Stage I Breast Cancer AJCC v8 × Simvastatin × Clear all
NCT05464810 2025-05-23

Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer

Emory University

Phase EARLY_PHASE1 Recruiting
40 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡